CXCL1 and non-small cell lung carcinoma: In this study, our results indicate that the expression level of CXCL1 is up-expressed in gefitinib-resistant NSCLC cells compared to the sensitive cells, and knockdown of CXCL1 significantly enhances the sensitivity of NSCLC cells to gefitinib.